共 50 条
- [1] Efficacy and safety of once weekly dulaglutide vs insulin glargine in combination with metformin and glimepiride in type 2 diabetes patients (AWARD-2)DIABETOLOGIA, 2014, 57 : S22 - S22Giorgino, F.Benroubi, M.Sun, J. -H.Zimmermann, A. G.Pechtner, V.
- [2] Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2)DIABETES CARE, 2015, 38 (12) : 2241 - 2249Giorgino, FrancescoBenroubi, MarianSun, Jui-HungZimmermann, Alan G.Pechtner, Valeria
- [3] Efficacy and Safety of Once-Weekly Dulaglutide vs. Insulin Glargine in Combination with Metformin and/or a Sulfonylurea in Predominantly Asian Patients with Type 2 DiabetesDIABETES, 2015, 64 : A74 - A74Wang, WeiqingRuiz, Luis NevarezFilippova, EkaterinaSong, Ki-HoGu, LiqunLi, PengfeiYang, Jun
- [5] Patient-Reported Outcomes with Once Weekly Dulaglutide vs. Insulin Glargine (AWARD-2)DIABETES, 2014, 63 : A251 - A251Reaney, MatthewYu, MariaVan Brunt, KatePechtner, ValeriaHayes, Risa P.
- [6] Efficacy and Safety of Once-Weekly Dulaglutide vs. Once-Daily Liraglutide in Japanese Patients with Type 2 DiabetesDIABETES, 2015, 64 : A285 - A285Takamura, ToshinariMiyagawa, Jun-IchiroOdawara, MasatoTakita, YasushiIwamoto, NoriyukiImaoka, Takeshi
- [7] Efficacy and safety of once-weekly dulaglutide monotherapy compared to glimepiride in Chinese patients with type 2 diabetes mellitusDIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 : 10 - 11Wang, WeiqingLi, PengfeiYang, JunGu, Liqun
- [8] Patient-Reported Outcomes with Once-Weekly Dulaglutide vs. Insulin Glargine, Both in Combination with Premeal Insulin Lispro, in Type 2 Diabetes Mellitus (AWARD-4)DIABETES, 2014, 63 : A607 - A607Reaney, MatthewYu, MariaVan Brunt, KateMilicevic, ZvonkoHayes, Clarice
- [9] The efficacy and safety of once-weekly, subcutaneous dulaglutide monotherapy compared to glimepiride in Asian patients with type 2 diabetes mellitusDIABETOLOGIA, 2015, 58 : S375 - S375Wang, W.Huang, C. -N.Young, M. -C.Li, P.Gu, L.Yang, J.
- [10] Efficacy and safety of once-weekly dulaglutide versus insulin glargine in Chinese patients with type 2 diabetes and different baseline glycaemic patternsDIABETOLOGIA, 2020, 63 (SUPPL 1) : S287 - S287Hou, J.Zhang, B.Li, Q.